Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade.
Effects of propentofylline on CNS remyelination in the rat brainstem.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Pain Affects Depression Through Anxiety, Fatigue, and Sleep in Multiple Sclerosis.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: A pilot study.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
[Consensus document on spasticity in patients with multiple sclerosis.]
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice.
Neuroprotective Effects of Oligodendrocyte Progenitor Cell Transplantation in Premature Rat Brain following Hypoxic-Ischemic Injury.
Efficacy of lower fingolimod doses in the treatment of MS.
Anti-drug antibodies: B-cell Immunity against therapy.
Multiple sclerosis in Sistan and Baloochestan, South East Iran.
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »